These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 383614)

  • 1. Opsonization of Cryptococcus neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages.
    Kozel TR; McGaw TG
    Infect Immun; 1979 Jul; 25(1):255-61. PubMed ID: 383614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opsonization of Cryptococcus neoformans by human immunoglobulin G: masking of immunoglobulin G by cryptococcal polysaccharide.
    McGaw TG; Kozel TR
    Infect Immun; 1979 Jul; 25(1):262-7. PubMed ID: 383615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsonization of encapsulated Cryptococcus neoformans by specific anticapsular antibody.
    Kozel TR; Follette JL
    Infect Immun; 1981 Mar; 31(3):978-84. PubMed ID: 7014468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils.
    Kozel TR; Highison B; Stratton CJ
    Infect Immun; 1984 Feb; 43(2):574-9. PubMed ID: 6363293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fc-dependent and Fc-independent opsonization of Cryptococcus neoformans by anticapsular monoclonal antibodies: importance of epitope specificity.
    Netski D; Kozel TR
    Infect Immun; 2002 Jun; 70(6):2812-9. PubMed ID: 12010967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
    Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
    Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the capsule in phagocytosis of Cryptococcus neoformans.
    Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
    Rev Infect Dis; 1988; 10 Suppl 2():S436-9. PubMed ID: 3055212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.
    Kozel TR; Gotschlich EC
    J Immunol; 1982 Oct; 129(4):1675-80. PubMed ID: 7050244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of macrophage Fc and C3b receptors in phagocytosis of immunologically coated Cryptococcus neoformans.
    Griffin FM
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3853-7. PubMed ID: 7022456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concomitant but not causal association between surface charge and inhibition of phagocytosis by cryptococcal polysaccharide.
    Kozel TR; Reiss E; Cherniak R
    Infect Immun; 1980 Aug; 29(2):295-300. PubMed ID: 7011970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall.
    Keller RG; Pfrommer GS; Kozel TR
    Infect Immun; 1994 Jan; 62(1):215-20. PubMed ID: 8262630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated neutrophils exhibit enhanced phagocytosis of Cryptococcus neoformans opsonized with normal human serum.
    Kozel TR; Pfrommer GS; Redelman D
    Clin Exp Immunol; 1987 Oct; 70(1):238-46. PubMed ID: 2961491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phagocytosis of Cryptococcus neoformans by rat alveolar macrophages.
    Bolaños B; Mitchell TG
    J Med Vet Mycol; 1989; 27(4):203-17. PubMed ID: 2677298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opsonization of Cryptococcus neoformans by a family of isotype-switch variant antibodies specific for the capsular polysaccharide.
    Schlageter AM; Kozel TR
    Infect Immun; 1990 Jun; 58(6):1914-8. PubMed ID: 2187813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effect of lung surfactant on alveolar macrophage defence mechanisms against Cryptococcus neoformans.
    Gross NT; Camner P; Chinchilla M; Jarstrand C
    Mycopathologia; 1998-1999; 144(1):21-7. PubMed ID: 10422270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opsonization and phagocytosis of Cryptococcus neoformans.
    Kozel TR
    Arch Med Res; 1993; 24(3):211-8. PubMed ID: 8298269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential stimulation of murine resident peritoneal cells by selectively opsonized encapsulated and acapsular Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    Infect Immun; 1988 Oct; 56(10):2544-51. PubMed ID: 3138176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form.
    Cross CE; Bancroft GJ
    Infect Immun; 1995 Jul; 63(7):2604-11. PubMed ID: 7790075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CR3-dependent phagocytosis by murine macrophages: different cytokines regulate ingestion of a defined CR3 ligand and complement-opsonized Cryptococcus neoformans.
    Cross CE; Collins HL; Bancroft GJ
    Immunology; 1997 Jun; 91(2):289-96. PubMed ID: 9227330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis.
    Kozel TR; Mastroianni RP
    Infect Immun; 1976 Jul; 14(1):62-7. PubMed ID: 780279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.